BACKGROUND & AIMS:
:The in vitro antibacterial activity of ciprofloxacin and 13 other antimicrobial drugs was evaluated with respect to 569 pathogens, mainly isolated from urine. Ciprofloxacin was found active in 96.1% of all of the Gram-positive and Gram-negative strains tested, amikacin in 90.6%, ceftazidime in 89.8%, ceftriaxone in 85.3%, piperacillin in 82.7%, tobramycin in 82.6%, gentamicin in 81.5%, aztreonam in 78.3%, nitrofurantoin in 72.6%, cotrimoxazole in 71.6%, cinoxacin in 71.0%, pipemidic acid in 70.6%, nalidixic acid in 66.7%, ampicillin in 50.1%. Ciprofloxacin was found to be the most active of the drugs studied against the bacterial strains which cause urinary, respiratory and other infections.
背景与目标:
:对主要从尿液中分离出来的569种病原体,评估了环丙沙星和其他13种抗菌药物的体外抗菌活性。环丙沙星在所有测试的革兰氏阳性和革兰氏阴性菌株中占96.1%,阿米卡星占90.6%,头孢他啶占89.8%,头孢曲松占85.3%,哌拉西林占82.7%,妥布霉素占82.6%,庆大霉素占81.5%。 ,氨曲南,78.3%,呋喃妥因,72.6%,卡曲美唑,71.6%,西沙星,71.0%,哌米酸,70.6%,萘啶酸,66.7%,氨苄青霉素,50.1%。已发现环丙沙星是研究的最有效的药物,可抵抗引起尿,呼吸道和其他感染的细菌菌株。